Cambridge Swinerton Builders to be Formally Launched on January 1, 2014

Cambridge Builders, Atlanta, and Swinerton Builders, San Francisco, announced today the formation of Cambridge Swinerton Builders, Inc. Cambridge and Swinerton began joint venture operations in 2010 and have constructed a series of successful multifamily residential projects in the southeastern United States.

Together they completed the SteelHouse apartment project in Orlando in 2012 and are currently constructing six other multifamily residential projects in Tampa, Jacksonville, Atlanta, and Nashville. Formally launching January 1, 2014, Cambridge Swinerton Builders, Inc., will continue to be based in Atlanta.

"The combination of Cambridge Builders' extensive experience in multifamily construction and Swinerton Builders' financial strength provides a strategic alliance for the two companies. We see continued opportunities in the multifamily market as well as in student housing, senior housing, and hospitality projects," said Mike Ruskin, founder of Cambridge Builders and president of Cambridge Swinerton Builders, Inc. Jeff Hoopes, CEO of Swinerton Builders, added, "We are excited about the partnership and look forward to its continued success and expansion."

About Cambridge Builders: Established in 1997, Cambridge specializes in types III and V wood-frame construction and is known throughout the southeastern United States for providing exceptional client-focused service in building multifamily residential, mixed-use, and related projects.

About Swinerton Builders: Swinerton provides commercial construction and construction management services throughout the United States and is a 100% employee-owned company. Founded in 1888 and celebrating its 125th anniversary in 2013, Swinerton is the preferred builder and trusted partner in every market it serves -- proudly leading with integrity, passion, and excellence.

Press release avilable from https://www.globenewswire.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.